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Summary.-The mean nuclear diameter of 100 breast cancers was measured on
tissue sections, to evaluate its importance for early prognosis. The cases were sub-
divided into 3 subgroups: small (25.5% of cases), medium (63.3%) and large (112%)
nuclei. Early recurrence and mortality rates were investigated in each of the
categories. Increasing nuclear size was shown to be related to mortality from
metastatic disease. However, large-nucleus tumours had an inverse relationship
with lymphnode involvement and possibly with recurrence rate. Hence, in our
material nuclear size as a sole criterion was not a good indicator of the early
behaviour of operable breast cancer.
SEEKING A VALUABLE DISCRIMINANT,
able to contribute to the identification of
breast-cancer patients who could take
advantage of a more appropriate treat-
ment, is of major concern at present. In
the past, attention has been drawn pri-
marily to long-term retrospective prog-
nostic studies, related to various types of
surgical and radiotherapeutic schedules;
the debate is continuing. Present workers
are more prone to scrutinize what happens
during the first months and years after
primary treatment (Friedell, 1978). One
of the aims of this new attitude is the
selection of patients who could obtain
some benefit either from adjuvant chemo-
therapy and/or earlybreastreconstruction.
One of these discriminants, the mean
nuclear diameter of tumour cells, has been
investigated on smears of breast-cancer
aspiration-biopsies (Kallenberger et al.,
1967; Savino & Koss, 1971; Wallgren et
al., 1976; Zajdela et al., 1979). In a pre-
vious report (van Bogaert & de Muylder,
1980) we showed that tissue fixation and
processing modify nuclear diameters;
hence a comparison with cytological data
is feasible only after correction by a factor
of 1-55. The present study was carried out
to verify in tissue sections a possible link
between 3 categories of nuclear size and
early prognosis.
MATERIALS AND METHODS
We collected a group of 100 breast car-
cinomas which had all been operated upon
by the same surgeon. All of them had been
followed up by this surgeon, together with
the radiotherapists of the Louvain Institut
des Tumeurs. Two patients were lost from
the follow-up and were discarded from the
prognostic evaluation. This left 98 cases,
most ofwhom had beentreated by a combined
radio-surgical treatment. Surgical manage-
ment consisted of a simple mastectomy with
axillary dissection.
At the time ofanalysis, after a mean obser-
vation period of2-5 years, 31 patients (31-6%)
had died, either of generalized metastatic
disease (23/98, 23-5%) or with no evidence of
recurrence (8/98: 8-1%). Sixty-seven patients
(68.4%) were still alive after a median follow-
up of 3-2 years (range, 5 months-8 years):
54 without recurrence (55-1%) and 13 with
proven metastatic disease (13-3%).
The tumours were diagnosed and classified
according to the criteria used at our institu-
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TABLE I.-Incidence of 3 cateq
nuclear size in tissue sections oj
ofbreast cancers
van Bogaert &
de Muylder
(1980)
Present series
Type 1
(%)
(<8 Zm)
Type 2
(%)
(8-12 am)
19-0 69-0
25-5 63-3
tion (van Bogaert & Maldague, H
technical conditions for measuring
diameters have already been repor
Bogaert & de Muylder, 1980).
The breast cancers were classifie
subgroups according to their meai
size. Small nuclear size (Type 1) wa
terized by a mean diameter <8 /A
large nuclear size (Type 3) reachec
>12 ,m; the medium size (Type
nuclei with a mean largest diameter
The reproducibility of the techni
checked by comparison with a previ
of 100 cases (van Bogaert & de
1980); Table I shows that the distri
nuclear types was comparable in th4
The mean values ofthe respective pe
illustrated in Table I were compa
gories of similar studies on aspiration-biopsy smears
f 2 series (Table II). Full comparison needs the
application ofthe correction factor 1-55.
Although our previous results (van Bogaert
Type)3 ;& de Muylder, 1980) showed a link between
M nuclear size and histologicaltypes and grades,
subdivision according to the latter criteria
was not attempted in the present series.
2-0 Actually, nuclear sizes overlap thehistological
11-2 subtypes; moreover, further subdivision of
the study material was deemed undesirable.
)78). The The value of the results was analysed by
nuclear x2.
rted (van
RESULTS
-d into 3
a nuclear As shown in Table III, the mean ages in
Ls charac- the different groups, distributed according
im, while to the biological behaviour of tumours
I a value (alive with or without recurrent disease,
2) being or dead from metastatic disease) were not
8-12 /1m. significantly different. Nevertheless, the
ique was subjects who died from a cause other than
Musylders cancer, belonged to a significantly older
ibution of group.
e 2 series. Axillary lymphnodes were invaded
rcentages (N+, regardless ofnumber) in 43.9% of all
tred with cases. There was a clear relationship
TABLE II.-Distribution of nuclear size in breast carcinomas
Aspiration-biopsy smears
Wallgren et al. Zajdela et al.
(1976) (%) (1979) (%)
(6< 12 ,um) 18-9 (,< 12 ,um) 39-1
(13-19 tim) 545-2 }(> 12 ,um) 60 9
Small
Medium
Large
Tissue sections
Mean values
from Table I (%)*
(<8) 22-3
(8-12) 66-1
(> 12) 11-6
* Approximate correspondence with cytological values (x 1-55): < 12-4 ,um, 12-4-18-6 ,um, > 18-6 ,um
respeictively.
TABLE III.-Early behaviour of breast cancer related to age, nodal status and nuclear size
Alive without
evidence of
recurrence
Alive with proven
metastasis
Death related to
cancer
Death unrelated
to cancer
N
52
Mean age
and range
at the
primary
treatment
(yrs)
57-3
(36-82)
15 55-6
(39-73)
22 56-5
(29-90)
9 72-6
(44-89)
Nodal status
No. (%)
N+ N-
14 38
(27-0) (73.0)
10
(66-7)
15
(68.2)
4
(44.4)
Nuclear types
No. (%)
I KN
1 2 3
14 32 6
(27.0) (61.5) (11.5)
Length of
follow up
(yrs)
3-7
(1 0-8 0)
5 4 10 1 2-6
(33-3) (26.7) (66.7) (6.6) (0-5-8-0)
7 4 14 4 2-2
(31-0) (18-2) (63.6) (18-2) (0-3-10-0)
5 3 6 0 1.5
(55-6) (33.3) (66.7) (0-0) (0-3-3-0)NUCLEAR DIAMETER AND BREAST CANCER PROGNOSIS
TABLE IV.-Infiuence of nuclear size on lymphnode metastasis, mortality and recurrence
rates
Axillary nodes
No. (%)
+_
8 17
(32 0) (68 0)
32 30
(516) }* (48 4)
3 8
(27.3) - (72.7)
43 55
(43-9) (56-1)
Alortality
No. (°h)
+ _ A
4
(16.0)
14
(22.6)1
4
(36.4)J
22
(22 4)
3
(12.0)
6
-***-+(9-7)
.* 0 l***
+-** (0 0)
9
(9.1)
Only significant comparisons are indicated. * P < 0 05; ** P < 0 01; *** P < 0-001.
between the nodal status and the subse-
quent evolution. Actually, 66 7% of the
patients with recurrent disease, and 68 2%
ofthose who died from metastatic general-
ization belonged to the N+ group. Living
subjects without recurrence, and those
who died from a cause unrelated to their
cancer, had respective incidence of 27-0
and 44.400 lymphnode metastases (Table
III).
Table IV shows, in a somewhat different
way, the distribution of the 3 nuclear-size
subgroups related to the evolution of the
disease. The relationship between nuclear
diameters and lymphnode involvement
shows a parallelism between increasing
diameters from Types 1 to 2 and a rising
incidence of metastases, respectively from
32-0-51.6%. However, the lowest inci-
dence of lymphnode metastases (27-3%)
was seen in tumours with large nuclei. The
only statistical difference which was sig-
nificant was between Types 2 and 3.
Mortality from disseminated disease
(M+) appeared to be related to increasing
nuclear size; statistical analysis is indi-
cated on Table IV. Mortality increased
from 16-0% (Type 1) to 22 6% (Type 2)
and 36-4% (Type 3). However, only the
difference between the Types 2 and 3 was
significant (P < 0.05). Comparison of re-
sults between the 2 mortality columns
yielded 2 highly significant values. This
could appear an invalid comparison, since
Type 3 tumours might occur in younger
patients who are less likely to die of un-
TABLE V.-Age according to nuclear type in
patients who died from metastatic disease
or from a cause unrelated to cancer
Nuclear
type
I
3
Age at deatl
related to
cancer
(yrs)
47-5
(29-70)
(n= 4)
57-7
(36-90)
(n= 14)
52-5
(45-67)
(n = 4)
Age at death
unrelated to
cancer
(yrs)
59*0
(44-74)
(n = 3)
70 4
(68-89)
(n=5)
n= number of cases in eachl subgroup.
related causes. To check this hypothesis
we compared the ages ofM+ and M- in the
3 nuclear types (Table V). The hypothesis
appears unlikely, since the youngest
patients were comprised in the Type 1 M+,
and none belonged to M- in the same
nuclear category. However, the number of
cases in each subgroup was too small to
allow definite conclusions.
In respect of recurrence, no statistical
difference was elicited between the 3
nuclear types.
Although the present preliminary data
are based on a limited number of cases,
and need more extended investigation,
one observation was rather constant.
There was a general trend for increasing
nodal metastases and mortality rates in
Type 2 over Type 1; in Type 3, supposed
to have the worst prognostic implication,
Nuclear
type
1
2
3
Total
No.
25
62
11
98
Recurrence
No. (Oo)
+ _
4
(16-0)
1.0
(16.1)
1
(9.1)
15
(15.3)
14
(56.0)
32
(51.6)
6
(54.5)
52 (53.0)
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the results appeared more favourable than
in Type 2. Perhaps this might be different
in larger series.
DISCUSSION
To the best of our knowledge few
studies have been reported on the prog-
nostic implications of nuclear size in
breast cancer. A lot of investigations have
been carried out using the nuclear grading
system proposed by Black & Speer (1957)
or using other nuclear parameters such as
nuclear crowding and lobulation (Stenk-
vist et al., 1979). Their major drawbacks
seem to be their lack of reproducibility
and their subjectivity (Freedman et al.,
1979; Stenkvist et al., 1979).
A more objective criterion, said to have
prognostic implications, was proposed by
Kallenberger et al. (1967) who correlated
sex chromatin, DNA content and nuclear
size with the evolution of breast cancer.
Wallgren & Zajicek (1976) studied survival
rates according to nuclear sizes on needle-
aspirates of 359 breast tumours; increase
in nuclear size was associated with de-
creased survival rate. Both 5-year and
10-year survival rates (93 and 82%) were
higher among patients whose smears
showed small (<9.5 ,um) or fairly small
(9.5-12 [kin) carcinoma nuclei. The lowest
rates (67 and 58% respectively) were
shown by those with large nuclei ( > 19
,urn) (Wallgren & Zajicek, 1976). These
d4ta were confirmed by Zajdela et al.
(1979) though they used different sub-
groups. Small nuclear types ( < 12 [km)
had a 5-year survival, free of disease, in
90% of cases vs only 5800 for the large
nuclear types (> 12 ,um).
All these studies have been carried out
on smears of aspiration-biopsies, but our
investigation used tissue sections. As a
first step, we had to verify the com-
parability of measurements; a compara-
tive study showed a shrinkage of breast
cancer cells and nuclei after fixation and
processing of tissue sections. Diameters on
smears are about 1.55x larger than on
tissue sections (van Bogaert & de Muylder,
1980). Therefore, we chose 8 and 12 ,um
as the lower and higher levels separating
small and large nuclei on tissue sections;
the 8jum level corresponded approxi-
mately to the value defining the cytological
small nuclear type. The respective per-
centages of our cases, as well as the sub-
division according to diameters, were
closer to that reported by Wallgren et al.
(1976) than to those of Zajdela et al.
(1979). Accordingly, some correspondence
does exist between cytological studies and
histological ones. Further classification
according to histological subtypes is more
debatable, primarily because it may lead
to unnecessary subdivisions; moreover,
different histological criteria for typing
and grading tumours may be used by
various observers. Thus, the corrected
values reported by Ashton et al. (1975) for
duct and lobular carcinomas were re-
spectively 7-5 + 1.8 and 6-3 + 0 9 ,um; their
mean nuclear sizes were distinctly lower
than in our material (10 0 + 1.5 and 7-5 +
1.5 ,um).
Concerning prognostic implications, the
sole convincing observation in our study
was the relationship between increasing
nuclear size and mortality from dissemi-
nated disease. Our finding is partly in
keeping with Friedell's (1978) observation
of a relationship between nuclear grade
and nodal status, except for the less
differentiated (large nuclei) tumours. The
author saw a systematic relationship
between recurrence and nuelear grade,
which was not apparent in our study.
Antoniades & Spector (1979) reported a
correlation between estrogen-receptor
(ER) values and cellularity, cell and
nuclear sizes. ER+ tumours had a mean
nuclear diameter of 9-7 ,um, ER- cancers
had a much larger, 11-1 um diameter.
Silvestrini et al. (1979) found an inverse
relationship between ER and proliferative
activity; differentiated tumours had a low
DNA-labelling index and high levels of
ER. Finally, Hahnel et al. (1979) demon-
strated that ER+ cancers had a signifi-
cantly better chance of survival, and
delayed recurrence even in N+ cases.NUCLEAR DIAMETER AND BREAST CANCER PROGNOSIS 541
Concurrent morphological and func-
tional data in the literature indicate a
biological relationship between nuclear
size, morphofunctional differentiation of
breast tumours, and their invasiveness.
In our preliminary findings there was a
significant increase in mortality from
disseminated breast cancer, which paral-
leled rising nuclear diameters. Other
parameters of behaviour were less clearly
influenced by this factor. The particular
behaviour of large-nucleus tumours might
be due to the small number ofcases. More-
over, more than one discriminant is prob-
ably needed to identify more accurately
the patients at risk of early recurrence.
The helpful assistance of Claudine Lahaye is
gratefully acknowledged.
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